Loading clinical trials...

Impact of a Sexological Follow-up on the Sexual Function in Patients With Cervix or Vaginal Cancer Treated by Radiotherapy and Brachytherapy | Clinical Trials | Clareo Health

COMPLETEDNA

Impact of a Sexological Follow-up on the Sexual Function in Patients With Cervix or Vaginal Cancer Treated by Radiotherapy and Brachytherapy

NCT03956498•Institut Claudius Regaud

View on ClinicalTrials.gov

Summary

Prospective, monocentric study evaluating the impact of a nurse-led sexological follow-up on sexual function in patients with cervix or vaginal cancer treated by radiotherapy and brachytherapy. The study procedure will consist of nurse-led sexological consultations, beginning before brachytherapy and until 2 months after brachytherapy. Evolution of female sexual function and vaginal symptoms will be done through clinical examinations and completion of quality of life and female sexual function questionnaires during radiation oncologist consultation and/or nurse-led sexological consultations until one year after end of brachytherapy. Study participation of each patient will be 12 months.

Eligibility

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

Inclusion Criteria

•1. 18 years or older
•2. Woman diagnosed with cervix or vaginal cancer, for whom a treatment by radiotherapy and brachytherapy has been decided
•3. Patient receiving for the first time an utero-vaginal or vaginal brachytherapy at "Institut Universitaire du Cancer de Toulouse - Oncopole"
•4. Easter Cooperative Oncology Group (ECOG) Performance Status ≤ 2
•5. All patients are eligible, regardless of their relationship status (in couple or not), their sexual orientation, and their hormonal status
•6. Patient willing to give informed consent before the study and before performing any study-related procedures
•7. Patient affiliated to a Social Health Insurance in France

Exclusion Criteria

•1. Patient not understanding the French language
•2. Patient for whom surgical treatment and brachytherapy has been decided
•3. Any psychological, familial, sociological or geographical condition that potentially hampers compliance with the study protocol and follow-up after treatment discontinuation schedule
•4. Patient who has forfeited his/her freedom by administrative or legal award or who is under legal protection (curatorship and guardianship, protection of justice

Locations (1)

Institut Universitaire du Cancer de Toulouse - Oncopole

Toulouse, France

Key Dates

Start Date

October 9, 2019

Primary Completion Date

February 20, 2022

Completion Date

February 20, 2022

Last Updated

March 24, 2022

Enrollment

ACTUAL participants

Conditions

Cervix CancerVaginal Cancer

Interventions

Patients with cervix or vaginal cancer treated by radiotherapy and brachytherapy

OTHER

E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

NCT05639972

HPV-Associated Cervical CarcinomaHPV-Related Carcinoma+15 more

View study

RECRUITINGNA

Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIV

NCT07428330

Cervix CancerHIV Infections+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 24, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Impact of a Sexological Follow-up on the Sexual Function in Patients With Cervix or Vaginal Cancer Treated by Radiotherapy and Brachytherapy

Inclusion Criteria

Exclusion Criteria

E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIV

Radiochemotherapy and Interventional Radiotherapy in Vaginal Cancer

ASk Questions in GYnecologic Oncology (ASQ-GYO)

Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies

Minimally Invasive Simple Hysterectomy in Low Risk Cervical Cancer